Target Details
| UniProt AC | P05107 |
|---|---|
| Gene Symbol | ITGB2 |
| Protein Name | Integrin beta-2 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF23105 (EGF_integrin) PF08725 (Integrin_b_cyt) PF07965 (Integrin_B_tail) PF00362 (Integrin_beta) PF17205 (PSI_integrin) |
Summary
- Multi-target molecules 373
- Clinical molecules 0
- Avg pChEMBL 7.14
KEGG Pathways (21)
- Amoebiasis
- Cell adhesion molecule (CAM) interaction
- Complement and coagulation cascades
- Hippo signaling pathway
- Human T-cell leukemia virus 1 infection
- IgSF CAM signaling
- Integrin signaling
- Legionellosis
- Leishmaniasis
- Leukocyte transendothelial migration
- Malaria
- Natural killer cell mediated cytotoxicity
- Neutrophil extracellular trap formation
- Pertussis
- Phagosome
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Rheumatoid arthritis
- Staphylococcus aureus infection
- Tuberculosis
- Viral myocarditis
Associated Diseases (1)
Active Molecules (373)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
XYLAVJHBJRSVOB
|
6.1 | IC50 | 3 | — | |
DJXITUPRUAXMQZ
|
6.1 | IC50 | 3 | — | |
GMUWOYDXNLWCCN
|
6.1 | IC50 | 3 | — | |
MGQXQCUUTIULTG
|
6.1 | IC50 | 3 | — | |
FZDTUJIPXUKHEY
|
6.1 | IC50 | 3 | — | |
LFXWWGSRHLWXMM
|
6.1 | IC50 | 3 | — | |
SEEYXMAOXPVGKQ
|
6.1 | IC50 | 3 | — | |
YCBXYRIEXMXDKQ
|
6.1 | IC50 | 3 | — | |
YCBXYRIEXMXDKQ
|
6.1 | IC50 | 3 | — | |
SJFBUCGDRXJLSO
|
6.1 | IC50 | 3 | — | |
FDHIKTFGAVFLBW
|
6.0 | IC50 | 3 | — | |
FXYDXLJEJBXFBD
|
6.0 | IC50 | 6 | — | |
PIDWOXMITGALID
|
6.0 | IC50 | 3 | — | |
QZDQYAWTHQIABF
|
6.0 | Kd | 3 | — | |
WCGMRWQSWALRBY
|
6.0 | IC50 | 3 | — | |
KRXBQXJYEYDJNX
|
6.0 | IC50 | 3 | — | |
ASZRMFOYZFBVKS
|
6.0 | IC50 | 3 | — | |
HHRSUWNKIITCSR
|
6.0 | IC50 | 3 | — | |
ODBJFDPUTWIUAM
|
6.0 | IC50 | 3 | — | |
KVFXBGFHMNALFK
|
6.0 | IC50 | 3 | — | |
IOBIQCAVWCTRDY
|
6.0 | IC50 | 3 | — | |
QHTCEKBPRLPPSG
|
6.0 | IC50 | 3 | — | |
YLBZKNBFLLAXRX
|
6.0 | IC50 | 3 | — |